Actively Recruiting
Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis
Led by Somogy Megyei Kaposi Mór Teaching Hospital · Updated on 2026-01-12
40
Participants Needed
1
Research Sites
133 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
* Objective assessment of clinical symptoms resulting from stroke, as well as changes in mobility and quality of life, and determination of changes resulting from therapies * Objective assessment of the quality of life, functionality, and clinical symptoms of patients with multiple sclerosis (MS) and determination of changes resulting from therapies * Comparison of measured data from the two main neurological patient groups (stroke, multiple sclerosis) and follow-up of changes in relation to themselves and each other. * Mapping the role of the placebo effect in neuromodulation devices by comparing subjective and objective outcomes. * Analyzing the expectations and experiences of patients receiving placebo treatment using quality of life questionnaires. * Analyzing the effects of the Mollii suit among subgroups of MS and stroke patients. * Assessing the safety, possible side effects, and tolerability of the Mollii suit. * Mapping changes in gait pattern due to the effects of therapy using 3D motion analysis. * Examining the maintenance effects of neuromodulation during a 1-month follow-up.
CONDITIONS
Official Title
Functional and Quality of Life Effects of the Mollii Neuromodulatory Suit in Patients With Stroke and Multiple Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Suffered a first ischemic stroke diagnosed by a neurologist using CT or MR imaging
- Neurological exam shows mobility and postural limitations
- Confirmed multiple sclerosis diagnosed by a neurologist based on MRI imaging
You will not qualify if you...
- History of multiple strokes
- Systolic blood pressure below 120 or above 160 mmHg
- Orthostatic hypotension
- Carotid artery stenosis
- Severe heart disease
- Hemophilia
- Traumatic brain injury
- Seizure disorder
- Untreated diabetes
- Abnormal electroencephalography
- Abnormal blood panel
- Use of sedatives
- Irregular medication use
- Severe aphasia (Western Aphasia Battery 64 25)
- Severe visual or hearing impairment
- Severe sensory dysfunction
- Severe orthopedic problems
- Other neurological conditions affecting motor function
- Alcoholism
- Drug use
- Smoking after stroke diagnosis
- Unable to walk at least 10 m with or without assistance in 6 minutes
- Berg Balance Scale score 64 32
- Barthel Index score 64 70
- Current participation in individual or group exercise program outside standard physical therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Somogy County Kaposi Mór Teaching Hospital
Kaposvár, Somogy County, Hungary, 7400
Actively Recruiting
Research Team
B
Barbara Kopácsi
CONTACT
J
József Dr. habil. Tollár
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here